PROTECT VIII kids extension study: Long-term safety and efficacy of BAY 94-9027 (damoctocog alfa pegol) in children with severe haemophilia A.
Maria Elisa MancusoTina BissKathelijn FischerMonika Maas EnriquezMacGregor SteeleMaria WangDespina Tseneklidou-StoeterSanjay AhujaGili KenetPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2021)
BAY 94-9027 showed long-term safety and efficacy for the prevention and treatment of bleeds in younger and older paediatric patients with severe haemophilia A.